Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
NCT00460408
·
clinicaltrials.gov ↗
COMPLETED
Status
501
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Macugen
Sponsor
Pfizer